The Specificities of Thrombotic Thrombocytopenic Purpura at Extreme Ages: A Narrative Review.

Joseph, Adrien; Joly, Bérangère S; Picod, Adrien; Veyradier, Agnès; Coppo, Paul

Joseph, Adrien; Joly, Bérangère S; Picod, Adrien; Veyradier, Agnès; Coppo, Paul.

Afiliación

Joseph A; Medical Intensive Care Unit, Saint-Louis Hospital, Public Assistance Hospitals of Paris, 75010 Paris, France.
Joly BS; French Reference Center for Thrombotic Microangiopathies, 75012 Paris, France.
Picod A; French Reference Center for Thrombotic Microangiopathies, 75012 Paris, France.
Veyradier A; Hematology Biology Department, Lariboisière Hospital, Public Assistance Hospitals of Paris, 75006 Paris, France.
Coppo P; EA-3518, Clinical Research in Hematology, Immunology and Transplantation, Institut de Recherche Saint-Louis, Université de Paris, 75571 Paris, France.

J Clin Med ; 12(9)2023 Apr 23.

Article en En | MEDLINE | ID: mdl-37176509

Palabras clave

ADAMTS13 protein; aging; caplacizumab; child; diagnosis; plasma exchange; prognosis; thrombotic microangiopathy; thrombotic thrombocytopenic purpura; von Willebrand factor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Clin Med Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google